At medac group, we believe that health is humanity’s most valuable resource. We never take it for granted. Since 1970, our mission has been to improve patients’ quality of life worldwide by making the best medical treatments available.
Over the years, we have evolved from a pharmaceutical company into an internationally recognized corporate group. With over 2,000 dedicated employees worldwide and two contract development and manufacturing organizations in Europe, we distribute our products to 91 countries. We channel our expertise to make a range of essential treatments accessible in our focus areas: rheumatology, urology, hematology, and oncology.
Our unified brand at medac signifies our dedication to customer proximity and high expertise, striving to fulfill our promise of enhancing human health. The brand claim, "Improving human health," positions us as a determined international pharmaceutical company aiming to make essential treatments available worldwide. Through collaboration with long-standing global business partners, our goal is to offer high-quality pharmaceutical products and services worldwide.
According to Frank Lucaßen, CEO of medac, "The consistent brand strategy across our company network worldwide reflects our international strength in a unified design and will shape our actions for years to come."
As part of the brand positioning the logo features a sovereign violet color, symbolizing confidence and resilience, evoking a sense of comfort, warmth, and boldness for maximum market impact. This distinctive color serves as a unique identifier in the competitive landscape, enhancing visibility and differentiation.
A significant focus in developing the corporate brand has been on highlighting medac's role as an employer. The employer brand aims to enhance medac's visibility and attractiveness as an international and future-oriented employer globally. This increases both the employees' identification with medac as an employer and awareness among potential applicants.
The corporate brand emphasizes our commitment to improving human health globally and reinforces our position as a dedicated and innovative pharmaceutical leader in its focus areas.